MedPath

ecessity of epidural analgesia in video-assisted thoracic surgery.

Phase 1
Conditions
Cancer pulmones
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
Registration Number
EUCTR2014-000760-18-DK
Lead Sponsor
Prof. Peter Licht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
124
Inclusion Criteria

Planned elective VATS lobectomy, wedge- or segmental resection (for the subsequent biomarker study, only lobectomy is a inclusion criteria, specified in protocol amendment July 27th 2016).
Patient has accepted to have epidural analgesia as part of the anaesthesia for the procedure.
Informed consent is attained.
Patient is over 18 years of age.
Patient is mentally able to answer questionnaires included in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 75

Exclusion Criteria

Allergies to any of the medications used in the trial.
History of previous peptic ulcer.
History of chronic pain to any degree that will interfere with quantification of pain postoperatively.
Dementia or reduced mental capacity to any degree that will interfere with quantification of pain postoperatively.
Pregnancy.
Contra-indications to placement of epidural catheter.
Any concurrent cancer disease or use of immune modulating drugs (criteria added as part of a protocol amendment July 27th 2016 for a subsequent biomarkers study)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To see if Video-Assisted Thoracic Surgery (VATS) lobectomy, wedge- or segmental resection can be done without epidural analgesia with no or only minor side effects.;Secondary Objective: Side effects of thoracic epidural analgesia.<br>Immonological aspects of use of epidural analgesia for VATS.<br><br>;Primary end point(s): 1) Intensity of pain. Self reported pain intensity 5 times a day both at rest and during activity until chest tube is removed or day 4 after operation is reached.<br><br>2) Consumption Rescue Analgesia - i.v. opioids. The consumption of i.v. opioids is registered daily until chest tube is removed or day 4 after operation is reached.;Timepoint(s) of evaluation of this end point: Postoperative day 0 to 4.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath